Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia
Launched by UNIVERSITY OF AARHUS · Mar 9, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a combination of exercise and patient education can help reduce pain in patients with hip dysplasia, compared to those receiving standard care. The main goal is to see if the patients who follow the exercise and education program report less pain over six months, as measured by a specific score that reflects their hip and groin outcomes.
To participate in the trial, individuals should be between the ages of 18 and 62, have a confirmed diagnosis of hip dysplasia, and have been experiencing hip or groin pain for at least three months. They should also be either waiting for surgery or not suitable for surgery. Participants will be randomly assigned to either the exercise and education group or the usual care group. Throughout the trial, they can expect to take part in various assessments related to their pain and overall hip function. It's important to note that certain health conditions or recent surgeries may exclude someone from participating, so potential volunteers should discuss their eligibility with the research team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Radiographically verified hip dysplasia by a Wiberg's centre edge (CE) angle of 10-25 degrees and an acetabular Index (AI) angle \>10 degrees
- • Hip and/or groin pain as primary pain for at least three months
- • Candidate for periacetabular osteotomy (PAO) but unwilling to undergo PAO, or on a waiting list for surgery (PAO) for 12 months or longer
- • Not candidate for PAO (negative impingement test, BMI \>25, hip osteoarthritis, age \>45 years or reduced hip range of motion)
- Exclusion Criteria:
- • Self-reported pain score \>80 points measured with Copenhagen Hip and Groin outcome score
- • Any major planned surgery (i.e. arthroplastic surgery or discectomy surgery)
- • BMI \>35
- • Acetabular retroversion defined by crossover sign and posterior wall sign
- • Calvé Legg Perthes or epiphysiolysis
- • Previous pelvic/hip surgery in index limb
- • Previous pelvic/hip surgery within the last 2 years in contralateral limb
- • Previous surgery due to herniated disc or spondylodesis
- • Previous arthroplastic surgery in the hip, knee or ankle
- • Physical (pregnancy/trauma), neurological, medical or rheumatic conditions severely affecting the hip function
- • Inadequacy in written and spoken Danish, mental illness or other conditions affecting the ability to follow mandatory procedures for participation
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Silkeborg, , Denmark
Patients applied
Trial Officials
Julie S Jacobsen, PhD
Principal Investigator
VIA University College
Inger Mechlenburg, DMSc
Study Director
Aarhus University Hospital
Kristian Thorborg, PhD
Study Chair
Copenhagen University Hospital, Hvidovre
Rasmus Ø Nielsen, PhD
Study Chair
University of Aarhus
Stig S Jakobsen, PhD
Study Chair
Aarhus University Hospital
Lisa G Oestergaard, PhD
Study Chair
Defactum, Central Denmark Region
Kjeld Søballe, PhD
Study Chair
Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials